Patent Assignment
Reel/Frame 064538/0708
Assignment of Assignor's Interest
Recorded: 2023-08-09
Pages: 5
Assignor
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2021-02-26
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, JAPAN
Covered Property
(1)
Formulations Comprising Glucocerebrosidase and Isofagomine
Application:
18/231,982 →
Publication:
US 2023/0381287
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.